NCT04966455

Brief Summary

Objective:To assess the effect of an intervention based on including 50 g of raisins (sultanas) daily in the diet for 3 months on improving cognitive performance, cardiovascular risk factors and inflammatory markers in a population of older adults without cognitive impairment. Methodology: Randomised two parallel-group clinical trial. Population: 80 patients between 70 and 80 years of age will be included, selected from primary care clinics in Salamanca and Zamora. Measurements and intervention: Participants included in the study will have a baseline visit and two evaluations visits at 3 and 6 months where cognitive performance (attention, executive functions, verbal memory, working memory and language) will be assessed using a brief neuropsychological battery; quality of life, using the WHOQol- AGE and EUROQOL-5D questionnaire; blood pressure; glycaemia; body composition, using an impedancemeter; and different markers of inflammation, interleukin (IL) 6, IL-1 and tumour necrosis factor alpha (TNF); and different markers of inflammation, interleukin (IL) 6, IL-1 and tumour necrosis factor alpha (TNF-α). Participants will be randomised using the Epidat 4.0 programme into 2 groups (control group and intervention group) with a ratio of 1:1. Both groups will be instructed to continue with their usual dietary pattern without changing their habits during the study period. Those in the control group will not receive any amount of raisins to their usual diet. The participants in the intervention group will receive 50 g of raisins and instructions on the time of day to take it (at night). The duration of this intervention will be 3 months. The daily nutritional intake of this amount of raisins is as follows: 146 kcal; 0.25 g of fat; 34 g carbohydrates of which 34 g sugars; 1.3 g protein; 1 g fibre. The total polyphenol content of total polyphenols from 50 g of raisinas is approximately 532,5 mg (phenols explorer database).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 19, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

September 20, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2023

Completed
Last Updated

December 19, 2023

Status Verified

December 1, 2023

Enrollment Period

1.6 years

First QC Date

July 1, 2021

Last Update Submit

December 18, 2023

Conditions

Keywords

Cognitive dysfunctionHeart Disease Risk FactorsVitisPolyphenolsClinical Trial

Outcome Measures

Primary Outcomes (1)

  • Cognitive impairment

    Evaluated by Montreal Cognitive Assessment (MoCA). Score (0-30). 30 (better score)

    3 months

Secondary Outcomes (6)

  • Health-related quality of life

    3 months

  • Health-related quality of life

    3 months

  • Health-related quality of life

    3 months

  • Blood pressure

    3 months

  • Plasma cholesterol

    3 months

  • +1 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

No intervention

Experimental group

EXPERIMENTAL

Supplementation of 50 g daily of rainsins for 3 months

Dietary Supplement: Raisins

Interventions

RaisinsDIETARY_SUPPLEMENT

Daily supplementation of 50 g of rainsins for 3 months

Experimental group

Eligibility Criteria

Age70 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • People of both sexes aged between 70 and 80 years.
  • The score on the Mini Mental State Examination (MMSE) must be greater than or equal to 24 points.
  • Self-employed to attend the centre where the study is carried out.
  • Signature of the informed consent form.

You may not qualify if:

  • Coronary or cerebrovascular atherosclerotic pathology.
  • Diabetes mellitus
  • Grade II or higher heart failure.
  • Moderate or severe chronic obstructive pulmonary disease.
  • Advanced renal or hepatic disease.
  • Severe mental illness.
  • Oncological disease under treatment diagnosed within the last 5 years or terminal condition.
  • Morbid obesity (IMC ≥ 40 kg/m2).
  • Intolerance and/or allergy to any of the grape components.
  • Any other circumstance at the criterion of the researchers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

José Ignacio Recio Rodriguez

Salamanca, 37005, Spain

Location

Related Publications (1)

  • Rodrigo-Gonzalo MJ, Recio-Rodriguez JI, Mendez-Sanchez R, Pablos-Hernandez MC, Gonzalez-Ramirez A, Gonzalez-Sanchez J, Fermoso-Palmero MJ, Puente-Gonzalez AS, Sanchez-Sanchez MC, Barbero-Iglesias FJ, Rihuete-Galve MI, Gonzalez-Manzano S. Effect of including a dietary supplement of raisins, a food rich in polyphenols, on cognitive function in healthy older adults; a study protocol for a randomized clinical trial. BMC Geriatr. 2023 Mar 29;23(1):182. doi: 10.1186/s12877-023-03882-6.

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Jose I Recio-Rodriguez, PhD

    University of Salamanca

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD in Biosciences, Principal Investigator

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 19, 2021

Study Start

September 20, 2021

Primary Completion

April 20, 2023

Study Completion

May 20, 2023

Last Updated

December 19, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations